Patents by Inventor Nicola Ammer

Nicola Ammer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of macimorelin in assessing growth hormone deficiency in children
    Patent number: 11644474
    Abstract: The present invention provides a method for measuring growth hormone level in a human child, including a method of assessing pituitary-related growth hormone deficiency in a human child as a stand-alone test. The method includes the steps of oral administration of an effective amount of macimorelin to the child, collecting from the child two or three post-administration blood samples within a range of about 60 minutes after administration, and determining the level of growth hormone in the samples. The method can be used for diagnosing pituitary-related growth hormone deficiency in a child when the peak level of determined growth hormone in the samples is below a cut-off value.
    Type: Grant
    Filed: July 14, 2021
    Date of Patent: May 9, 2023
    Assignee: ÆTERNA ZENTARIS GMBH
    Inventors: Nicola Ammer, Michael Teifel, Beate Aue
  • USE OF MACIMORELIN IN ASSESSING GROWTH HORMONE DEFICIENCY IN CHILDREN
    Publication number: 20220026449
    Abstract: The present invention relates to a method for measuring growth hormone level in a human child, including a method of assessing pituitary-related growth hormone deficiency in a human child as a stand-alone test. The method comprises oral administration of an effective amount of macimorelin to the child, collecting from the child two or up to four post-administration blood samples within a range of about 90 minutes after administration, and determining the level of growth hormone in the samples. The method can be used for diagnosing pituitary-related growth hormone deficiency in a child when the peak level of determined growth hormone in the samples is below a cut-off value.
    Type: Application
    Filed: July 14, 2021
    Publication date: January 27, 2022
    Inventors: Nicola Ammer, Michael Teifel, Beate Aue
  • Method of assessing growth hormone deficiency in humans by a macimorelin containing composition
    Patent number: 10288629
    Abstract: The present invention provides a method for measuring growth hormone level in a human or animal subject, including a method of assessing pituitary-related growth hormone deficiency in a human or animal subject, after macimorelin oral administration to the subject.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: May 14, 2019
    Assignee: Aeterna Zentaris, Inc.
    Inventors: Nicola Ammer, Gilbert Muller, Richard Sachse, Herbert Sindermann